Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sickle Cell Data Show Value Of Novartis’s Recently Acquired SEG101

Dec 06 2016

• By Mandy Jackson

Sickle cell anemia, 3D illustration showing blood vessel with normal and deformated crescent-like red blood cells

Related Content

Sickle cell therapies: GlycoMimetics and others target underlying causes

Dec 20 2013

Novartis Buys Selexys As Competitors Stumble In Sickle Cell

Nov 21 2016

ASH 2016 Preview: Don't Miss These 10 Data Presentations

Nov 24 2016

Pfizer finally begins Phase III for GlycoMimetics sickle cell drug

Jun 25 2015

Related Companies

Novartis AG

Pfizer Inc.

GlycoMimetics, Inc.

Selexys Pharmaceuticals Corporation

Additional Topics

Research & Development Clinical Trials Blood & Coagulation Disorders BioPharmaceutical

More from R&D

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window